Breaking News Instant updates and real-time market news.

FL

Foot Locker

$46.10

-2.69 (-5.51%)

, ADSK

Autodesk

$122.99

-2.76 (-2.19%)

18:56
11/20/18
11/20
18:56
11/20/18
18:56

Fly Intel: After Hours Movers

UP AFTER EARNINGS: Foot Locker (FL) up 14.8%... Autodesk (ADSK) up 7.9%... BJ's Wholesale (BJ) up 7.2%... Keysight Technologies (KEYS) up 5.8%... Copart (CPRT) up 4.7%... 21Vianet Group (VNET) up 2.6%... The Gap (GPS) up 0.7%. DOWN AFTER EARNINGS: Bilibili (BILI) down 7.6%. ALSO LOWER: DexCom (DXCM) down 1.5% after mixed shelf offering.

FL

Foot Locker

$46.10

-2.69 (-5.51%)

ADSK

Autodesk

$122.99

-2.76 (-2.19%)

BJ

BJ's Wholesale

$19.85

-0.22 (-1.10%)

KEYS

Keysight Technologies

$54.35

-1.23 (-2.21%)

CPRT

Copart

$47.30

-1.255 (-2.58%)

VNET

21Vianet

$11.20

-0.1 (-0.88%)

GPS

Gap

$24.65

-0.79 (-3.11%)

BILI

Bilibili

$13.61

0.575 (4.41%)

DXCM

DexCom

$119.89

-1.34 (-1.11%)

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 21

    Nov

  • 26

    Nov

  • 27

    Nov

  • 04

    Dec

  • 04

    Dec

  • 04

    Dec

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 03

    Mar

FL Foot Locker
$46.10

-2.69 (-5.51%)

09/27/18
JEFF
09/27/18
NO CHANGE
Target $60
JEFF
Buy
Foot Locker intra-quarter checks show momentum is building, says Jefferies
Jefferies analyst Janine Stichter says that with two-thirds of Q3 now complete, she looked at various data points to triangulate around Foot Locker's progress intra-quarter. Search interest and site traffic data suggest the Nike Air Max platform is driving growth and that basketball is showing some signs of stabilizing, Stichter tells investors in a research note. The analyst believes momentum is building for Foot Locker and that earnings upside, coupled with multiple expansion, could drive the stock higher. With the stock trading well below historical valuation levels and peers, the market doubts Foot Locker's ability to maintain its positive comp momentum in the second half of 2018, Stichter says. However, she thinks her work reinforces confidence on the company's positive comp and margin trajectory. The analyst reiterates a Buy rating on Foot Locker with a $60 price target.
10/09/18
BARD
10/09/18
NO CHANGE
Target $55
BARD
Neutral
Foot Locker added as Fresh Pick at Baird
Baird analyst Jonathan Komp added the Fresh Pick designation to Foot Locker (FL) shares as Nike's (NKE) improving outlook has increased his near-term conviction the company can deliver better same-store sales. Based on the prospects for better comps in the second half, he is more confident in current estimates and sees an upward bias to valuation. Komp maintained his Neutral rating and raised his price target to $55 from $52 on Foot Locker shares.
11/12/18
COWN
11/12/18
NO CHANGE
Target $56
COWN
Market Perform
Foot Locker price target raised to $56 from $46 at Cowen
Cowen analyst John Kernan raised his price target on Foot Locker to $56 from $46 and also raised his estimates following channel checks which show significantly improved full-price selling trends in North America. Kernan said concerns over long-term growth and margin structure keep him at Market Perform on Foot Locker shares.
11/14/18
LEHM
11/14/18
NO CHANGE
Target $70
LEHM
Overweight
Foot Locker well positioned to meet this quarter's guidance, says Barclays
Barclays analyst Matthew McClintock believes Foot Locker (FL) is well positioned to meet guidance this quarter with further acceleration into Q4 and beyond. The analyst, who acknowledges that comp expectations are likely for flat to slightly negative, says Nike's (NKE) recently reported wholesale revenue growth of 5.2% is a "strong indication of an inflection" in Foot Locker's business. The analyst is estimating a 2.6%, above the 1.8% consensus, increase in comp store sales for Foot Locker and earnings per share of 94c, or a 3c beat. He keeps an Overweight rating on the shares with a $70 price target.
ADSK Autodesk
$122.99

-2.76 (-2.19%)

08/29/18
ARGS
08/29/18
NO CHANGE
ARGS
Hold
Autodesk 'turning the corner in business transition', says Argus
Argus analyst Joseph Bonner kept his Hold rating on Autodesk but raised his FY19 EPS target to 94c from 90c after the company's most recent earnings beat. The analyst notes that Q2 marks the 2nd consecutive quarter of profitability and believes that Autodesk "may have just turned the corner" on its business transition, as the management looks for positive earnings in FY19 and a ramp in FY20. Bonner attributes his neutral stance to concerns about the volatility of the construction and manufacturing sectors and the yet-to-materialize promises of increased infrastructure spending from the Trump White House.
08/29/18
BARD
08/29/18
NO CHANGE
Target $165
BARD
Outperform
Autodesk Fresh Pick designation removed at Baird
Baird analyst Rob Oliver removed the Fresh Pick designation from Autodesk, but he remains bullish longer-term. The removal was made following its share price appreciation, but he said he has increased confidence in its long-term cash flow projections. He said he would use any weakness to accumulate or add to positions. Oliver maintained his Outperform rating and $165 price target on Autodesk shares.
09/20/18
ADAM
09/20/18
NO CHANGE
Target $180
ADAM
Buy
Autodesk price target raised to $180 from $165 at Canaccord
Canaccord analyst Richard Davis raised his price target on Autodesk to $180 from $165 after meeting with management. The analyst said investors dialogue has changed for the better as the focus now seems to be on longer-term, strategic topics including the opportunity in construction, digitization of operations, sales alignment, and the value creation that accompanies full subscription adoption. Davis reiterated his Buy rating on Autodesk shares.
08/24/18
FBCO
08/24/18
NO CHANGE
Target $160
FBCO
Outperform
Autodesk price target raised to $160 from $150 at Credit Suisse
Credit Suisse analyst Brad Zelnick raised his price target for Autodesk to $160 citing last night's "strong" Q2 results. The analyst says that while fiscal 2019 guidance for annualized recurring revenue growth was maintained at 28%-30%, he remains encouraged by continued strength in Maintenance-to-Subscription conversions and Collections/BIM 360 adoption momentum. Zelnick maintains an Outperform rating on Autodesk shares.
BJ BJ's Wholesale
$19.85

-0.22 (-1.10%)

10/02/18
SBSH
10/02/18
INITIATION
Target $31
SBSH
Buy
BJ's Wholesale resumed with a Buy at Citi
Citi analyst Kate McShane resumed coverage of BJ's Wholesale Club Holdings with a Buy rating and $31 price target. The analyst continues to expect "solid" revenue growth from BJ's and she also see room for margin expansion from the company's initiatives related to procurement, private-label sales and overhead cost control.
10/02/18
10/02/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. WillScot (WSC) initiated with a Buy at Deutsche Bank. 2. Scientific Games (SGMS) initiated with a Buy at SunTrust. 3. Omega Healthcare (OHI) initiated with a Neutral at MUFG. 4. BJ's Wholesale (BJ) resumed with a Buy at Citi. 5. Matthews (MATW) initiated with a Buy at Buckingham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/17/18
OPCO
10/17/18
INITIATION
OPCO
Perform
BJ's Wholesale initiated with a Perform at Oppenheimer
Oppenheimer analyst Rupesh Parikh initiated BJ's Wholesale with a Perform rating, stating that he sees potential for positive comp growth to persist, but is less confident in the company's ability to gain share. He views the stock's current valuation as fair given the potential for comp growth to persist below other warehouse club peers.
10/18/18
10/18/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) initiated with an Outperform at Wedbush. 2. BJ's Wholesale (BJ) initiated with a Perform at Oppenheimer. 3. Comcast (CMCSA) initiated with an Outperform at Evercore ISI. 4. Thomson Reuters (TRI) reinstated with a Neutral at Goldman Sachs. 5. Atomera (ATOM) initiated with a Buy at Roth Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
KEYS Keysight Technologies
$54.35

-1.23 (-2.21%)

10/18/18
GSCO
10/18/18
UPGRADE
GSCO
Buy
Keysight Technologies upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Toshiya Hari upgraded Keysight Technologies to Buy while re-stacking his ratings in the Semiconductors space.
10/18/18
GSCO
10/18/18
UPGRADE
Target $76
GSCO
Buy
Goldman says Keysight exposed to 'right' markets, upgrades to Buy from Neutral
Goldman Sachs analyst Toshiya Hari upgraded Keysight Technologies to Buy from Neutral and raised his price target for the shares to $76 from $66. The company's sizable exposure to two end-markets, Communications and Defense, makes it defensively positioned within the Semiconductor space, Hari tells investors in a research note on the sector where he made several changes to his ratings. The analyst, who sees improving growth in the Wireless Communications and Defense end markets, believes Keysight is exposed to the "right" markets. His new price target represents 20% share upside.
10/18/18
GSCO
10/18/18
UPGRADE
Target $305
GSCO
Conviction Buy
Semi re-stack puts Nvidia on Goldman Conviction List with 25% upside
Goldman Sachs analyst Toshiya Hari this morning added Buy-rated Nvidia (NVDA) to his firm's Conviction List while lowering his price target for the shares to $305 from $324. The stock in morning trading is up 85c to $243.91. Following a "significant correction" in the stock's valuation, the analyst expects Nvidia's "idiosyncratic growth drivers," like its product cycle in Gaming and potential share gains in Data Center, to drive share outperformance. While lowering his January quarter earnings per share estimate to $1.90 from $2.28 to reflect potential volume and average selling price weakness in the Gaming business, Hari recommends investors to buy the stock at current levels with his long-term thesis intact. He sees potential upside of 25% for Nvidia shares. Positive earnings revisions post the Q3 earnings report should serve as a positive catalyst for the stock, contends the analyst. Putting Nvidia on his firm's Conviction List was part of Hari's rating re-stack in the Semiconductors sector. Also this morning, the analyst downgraded both Analog Devices (ADI) and Maxim Integrated Products (MXIM) to Sell from Neutral, downgraded Teradyne (TER) to Neutral from Buy, upgraded both Keysight Technologies (KEYS) and NXP Semiconductors (NXPI) to Buy from Neutral, and upgraded Texas Instruments (TXN) to Neutral from Sell. Hari also maintained a Conviction List Buy rating on Xilinx (XLNX) and a Sell rating on Intel (INTC).
10/22/18
STFL
10/22/18
INITIATION
STFL
Buy
Keysight Technologies resumed with a Buy at Stifel
Stifel analyst John Marchetti resumed coverage of Keysight Technologies with a Buy rating and $73 price target, citing "company specific tailwinds around 5G, automotive and software combined with a generally constructive view of the core T&M market to drive revenue growth above the company's core target of 4%-5%," along with the company's flexible cost structure and strong operational controls.
CPRT Copart
$47.30

-1.255 (-2.58%)

09/20/18
RHCO
09/20/18
NO CHANGE
Target $63
RHCO
Buy
Copart price target raised to $63 from $60 at SunTrust
SunTrust analyst Stephanie Benjamin raised her price target on Copart to $63 and kept his Buy rating, saying that today's stock price weakness following its Q4 earnings miss is a "buying opportunity". The analyst cites "favorable secular tailwinds" such as "higher accident rates", higher vehicle pricing, and expectations of further international expansion. Benjamin notes that his price target implies a multiple of 18-times his expected FY20 EBITDA, which is above the company's historical average of 13- to 17-times, but believes the premium is justified by "some of the most attractive industry dynamics in the last three years".
09/20/18
GABE
09/20/18
UPGRADE
GABE
Buy
Copart upgraded to Buy from Hold at Gabelli
Gabelli analyst Matthew Paige upgraded Copart (CPRT) to Buy from Hold as he raised his valuation multiple to 15x EBITDA from 12x to reflect the premium he believes the stock deserves relative to KAR Auction Service (KAR) given its EBITDA margin advantage and his view that current market conditions better support the salvage auction business than wholesale.
09/21/18
JPMS
09/21/18
DOWNGRADE
Target $47
JPMS
Underweight
Copart downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Ryan Brinkman downgraded Copart (CPRT) to Underweight and lowered his price target for the shares to $47 from $48. The company reported softer than expected Q4 results this week but trades at "near record multiples" of earnings and EBITDA, Brinkman tells investors in a research note. The analyst sees a potential pair trade in going long KAR Auction (KAR) shares, and short Copart shares, to capitalize on the "valuation disconnect."
09/20/18
09/20/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ralph Lauren (RL) upgraded to Neutral from Underweight at Piper Jaffray with analyst Erinn Murphy, who remains concerned about the sustainability of Ralph Lauren's sales group, saying earnings estimates are likely to continue to grind higher given the company's "sound" cost control and favorable margin mix shift. 2. Caterpillar (CAT) upgraded to Outperform from Neutral at Baird with analyst Mig Dobre saying he believes demand growth should continue into 2019. 3. Copart (CPRT) upgraded to Buy from Hold at Gabelli with analyst Matthew Paige saying he raised his valuation multiple to 15x EBITDA from 12x to reflect the premium he believes the stock deserves relative to KAR Auction Service (KAR) given its EBITDA margin advantage and his view that current market conditions better support the salvage auction business than wholesale. 4. Arcturus Therapeutics (ARCT) upgraded to Strong Buy from Buy at WBB Securities. 5. First BanCorp (FBP) upgraded to Buy from Neutral at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
VNET 21Vianet
$11.20

-0.1 (-0.88%)

10/03/18
10/03/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. XPO Logistics (XPO) initiated with a Buy at Jefferies. 2. Allegiance Bancshares (ABTX) initiated with a Strong Buy at Raymond James. 3. 21Vianet (VNET) initiated with a Buy at Jefferies. 4. Frontdoor (FTDR) initiated with a Buy at Gabelli. 5. Anixa Biosciences (ANIX) initiated with a Buy at B. Riley FBR. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/03/18
JEFF
10/03/18
INITIATION
Target $14.2
JEFF
Buy
Jefferies starts 21Vianet with Buy rating, $14.20 price target
Jefferies analyst Rex Wu initiated coverage of 21Vianet with a Buy rating and $14.20 price target. The analyst likes 21Vianet's "leading position" in the "undersupplied" Tier-1 city data center market and believes its recovery is on track under new management.
10/02/18
JEFF
10/02/18
INITIATION
Target $14.2
JEFF
Buy
21Vianet initiated with a Buy at Jefferies
Target $14.20.
08/20/18
MSCO
08/20/18
NO CHANGE
MSCO
21Vianet named a long Research Tactical Idea at Morgan Stanley
GPS Gap
$24.65

-0.79 (-3.11%)

11/01/18
RBCM
11/01/18
NO CHANGE
Target $30
RBCM
Sector Perform
Gap price target lowered to $30 from $34 at RBC Capital
RBC Capital analyst Brian Tunick lowered his price target on The Gap to $30 and kept his Sector Perform rating, saying his promotional analysis suggests that the company's brand has suffered a "step back" in Q3. The analyst notes that the stock is already pricing in some of the investor skepticism about getting all 3 of its segment into positive comps while also lowering his FY18 EPS view by 5c to $2.55 and FY19 EPS by 25c to $2.55.
10/26/18
10/26/18
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. L Brands (LB) initiated with a Buy at Goldman Sachs while Gap (GPS) was initiated with a Neutral. 2. Iridex (IRIX) initiated with a Buy at Stifel. 3. Xilinx (XLNX) assumed with a Market Perform at William Blair. 4. Novan (NOVN) initiated with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/25/18
GSCO
10/25/18
INITIATION
Target $28
GSCO
Neutral
Gap initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Alexandra Walvis initiated Gap with a Neutral rating and a price target of $28. The analyst is positive on the company's shift to "higher growth, higher margin value formats", the expansion of its omnichannel sales, and its "stronger consumer environment", but also sees a "key risk" to its "value based portfolio" coming from the "intensifying private label and online apparel competition".
10/25/18
GSCO
10/25/18
INITIATION
Target $28
GSCO
Neutral
Gap initiated with a Neutral at Goldman Sachs
Price target $28.
BILI Bilibili
$13.61

0.575 (4.41%)

05/07/18
JPMS
05/07/18
INITIATION
Target $14
JPMS
Overweight
Bilibili initiated with an Overweight at JPMorgan
JPMorgan analyst Alex Yao started Bilibili with an Overweight rating and $14 price target. The company is an "undisputed vertical leader" among video content platforms targeting Generation Z, with "unique social features and rich content library" in animation, comics and gaming, Yao tells investors in a research note. He believes Bilibili's "multifaceted" revenue models are at the early development stage.
05/07/18
05/07/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amazon.com (AMZN) initiated with an Outperform at Telsey Advisory. 2. Zuora (ZUO) initiated with a Buy at Needham and Jefferies, an Equal Weight at Morgan Stanley, and a Neutral at Goldman Sachs. 3. Bilibili (BILI) initiated with an Overweight at JPMorgan. 4. Cloudera (CLDR) initiated with a Buy at Craig-Hallum. 5. Scynexis (SCYX) assumed with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/24/18
MSCO
09/24/18
DOWNGRADE
MSCO
Equal Weight
Bilibili downgraded to Equal Weight from Overweight at Morgan Stanley
09/24/18
09/24/18
DOWNGRADE
Target $11

Equal Weight
Morgan Stanley downgrades Bilibili to Equal Weight after pushing out profit view
As previously reported, Morgan Stanley analyst Alex Poon downgraded Bilibili to Equal Weight from Overweight, telling investors that he thinks the company's transformation from a game-centric company to a profitable social platform is still in its early stages. Given that its investments are outpacing revenue growth, Poon does not expect operating profit to turn positive until 2020, he stated. While he remains positive on the long-term story, the valuation of Bilibili shares "appears full," added Poon, who lowered his price target on the stock to $11 from $13.50.
DXCM DexCom
$119.89

-1.34 (-1.11%)

11/12/18
PIPR
11/12/18
NO CHANGE
PIPR
Piper continues to like pure play diabetes stocks after conference
Piper Jaffray analyst JP McKim left this weekend's Diabetes Technology Meeting feeling that DexCom (DXCM) "has a lot in its pipeline" and remains a few steps ahead of the competition, Insulet (PODD) is having "great success" in the pharmacy and is on the forefront of cybersecurity, and Tandem Diabetes (TNDM) remains in a "strong position to take market share." The analyst continues to like pure play diabetes names and keeps an Overweight rating on all three names.
11/07/18
JEFF
11/07/18
NO CHANGE
Target $148
JEFF
Buy
DexCom price target raised to $148 from $125 at Jefferies
Jefferies analyst Raj Denhoy raised his price target for DexCom (DXCM) to $148 saying the company posted "strong" Q3 results. Improving market access from pharmacy benefit is driving patient adds and helping blunt any advantage for Abbott's (ABT) Libre, says the analyst. He keeps a Buy rating on DexCom citing strong G6 adoption, new patients accelerating and still underpenetrated markets.
11/07/18
SPHN
11/07/18
NO CHANGE
Target $170
SPHN
Overweight
DexCom price target raised to $170 from $160 at Stephens
Stephens analyst Chris Cooley raised his price target on DexCom shares to $170 from $160 following the company's Q3 report and revenue guidance increase. He sees DexCom being well positioned to continued posting organic growth "in the top echelon of med tech" while realizing operating leverage. Cooley maintains an Overweight rating on DexCom shares.
11/07/18
OPCO
11/07/18
NO CHANGE
Target $150
OPCO
Outperform
DexCom price target raised to $150 form $125 at Oppenheimer
Oppenheimer analyst Steven Lichtman raised his price target for DexCom to $150 from $125 following quarterly results. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$257.42

2.33 (0.91%)

10:32
12/19/18
12/19
10:32
12/19/18
10:32
Periodicals
Senate to introduce short-term measure to avoid government shutdown, CNBC says »

The Senate will introduce…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$257.42

2.33 (0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:31
12/19/18
12/19
10:31
12/19/18
10:31
General news
Crude inventories for week of December 14 »

Crude oil inventories…

ABX

Barrick Gold

$13.82

-0.07 (-0.50%)

10:30
12/19/18
12/19
10:30
12/19/18
10:30
Options
Heavy volume in Barrick Gold downside Jan puts »

Heavy volume in Barrick…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JKS

JinkoSolar

$10.99

-0.05 (-0.45%)

10:29
12/19/18
12/19
10:29
12/19/18
10:29
Initiation
JinkoSolar initiated  »

JinkoSolar initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Dec

10:25
12/19/18
12/19
10:25
12/19/18
10:25
General news
Treasury Action: flattening is the trade ahead of the FOMC »

Treasury Action:…

10:25
12/19/18
12/19
10:25
12/19/18
10:25
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

10:25
12/19/18
12/19
10:25
12/19/18
10:25
Conference/Events
UBS retail analyst to hold an analyst/industry conference call »

Retail Analyst Sole…

10:20
12/19/18
12/19
10:20
12/19/18
10:20
General news
FX Action: The dollar »

FX Action: The dollar…

SPY

SPDR S&P 500 ETF Trust

$257.02

1.93 (0.76%)

10:20
12/19/18
12/19
10:20
12/19/18
10:20
Options
Size ratio spread in SPYders weekly options »

Size ratio spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:20
12/19/18
12/19
10:20
12/19/18
10:20
General news
Treasury Action: yields remained pinned lower »

Treasury Action: yields…

ULTA

Ulta Beauty

$245.00

4.07 (1.69%)

, MTCH

Match Group

$42.58

0.6 (1.43%)

10:19
12/19/18
12/19
10:19
12/19/18
10:19
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

ULTA

Ulta Beauty

$245.00

4.07 (1.69%)

MTCH

Match Group

$42.58

0.6 (1.43%)

SSTI

ShotSpotter

$30.30

1.12 (3.84%)

OKTA

Okta

$66.09

3.32 (5.29%)

CLLS

Cellectis

$18.35

0.6 (3.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 09

    Jan

  • 16

    Jan

ALKS

Alkermes

$31.58

-0.25 (-0.79%)

, ADI

Analog Devices

$87.50

-0.57 (-0.65%)

10:19
12/19/18
12/19
10:19
12/19/18
10:19
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

ALKS

Alkermes

$31.58

-0.25 (-0.79%)

ADI

Analog Devices

$87.50

-0.57 (-0.65%)

UAA

Under Armour

$18.63

-0.18 (-0.96%)

UA

Under Armour

$17.21

-0.18 (-1.04%)

MU

Micron

$33.30

-0.82 (-2.40%)

JPM

JPMorgan

$99.31

0.79 (0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 08

    Jan

  • 08

    Jan

  • 31

    Jan

  • 26

    Feb

  • 03

    Mar

MDT

Medtronic

$92.20

0.18 (0.20%)

, MASI

Masimo

$106.37

1.08 (1.03%)

10:19
12/19/18
12/19
10:19
12/19/18
10:19
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

MDT

Medtronic

$92.20

0.18 (0.20%)

MASI

Masimo

$106.37

1.08 (1.03%)

DRI

Darden

$103.74

-0.08 (-0.08%)

BBY

Best Buy

$52.56

0.57 (1.10%)

GE

General Electric

$7.78

0.505 (6.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
12/19/18
12/19
10:17
12/19/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
12/19/18
12/19
10:16
12/19/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
12/19/18
12/19
10:15
12/19/18
10:15
General news
U.S. existing home sales rose 1.9% to 5.320 M in November »

U.S. existing home sales…

10:15
12/19/18
12/19
10:15
12/19/18
10:15
General news
Breaking General news story  »

Week of 12/14 EIA…

XLU

Utilities SPDR

$54.42

-0.21 (-0.38%)

10:10
12/19/18
12/19
10:10
12/19/18
10:10
Options
18.8K SPDR Utility Fund Dec 51 - 53 put spreads trade 12c »

18.8K SPDR Utility Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FND

Floor & Decor

$26.63

0.09 (0.34%)

10:06
12/19/18
12/19
10:06
12/19/18
10:06
Recommendations
Floor & Decor analyst commentary  »

Morgan Stanley says Floor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWA

BorgWarner

$35.14

0.73 (2.12%)

10:05
12/19/18
12/19
10:05
12/19/18
10:05
Hot Stocks
BorgWarner extends agreement to be Official Turbocharger Partner of INDYCAR »

BorgWarner and INDYCAR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEED

Origin Agritech

$6.37

(0.00%)

10:03
12/19/18
12/19
10:03
12/19/18
10:03
Hot Stocks
Origin Agritech announces establishment of two additional joint ventures »

Origin Agritech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:02
12/19/18
12/19
10:02
12/19/18
10:02
General news
Existing Home Sales data reported »

November Existing Home…

APD

Air Products

$156.68

1.95 (1.26%)

10:02
12/19/18
12/19
10:02
12/19/18
10:02
Hot Stocks
Air Products to supply three nitrogen generation plants to energy project »

Air Products and N.V.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$169.62

-15.39 (-8.32%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Hot Stocks
FedEx falls -8.4% »

FedEx is down -8.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTSI

FTS International

$7.54

-0.7 (-8.50%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Hot Stocks
FTS International falls -8.6% »

FTS International is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.